U of A virologist David Evans (right) and research associate Ryan Noyce are teaming up with U.S.-based Tonix Pharmaceuticals to develop and test a vaccine against COVID-19, targeting the “spike” protein the coronavirus uses to enter cells and cause infection. (Photo: Melissa Fabrizio)

U of A researchers and Tonix Pharmaceuticals race to develop and test candidate vaccines for COVID-19

Posted on

Partnerships like this one can dramatically accelerate efforts to move research from lab to community, says virologist.

University of Alberta researchers launched a joint effort with U.S.-based Tonix Pharmaceuticals to develop and test a vaccine against COVID-19.

The researchers hope their unique delivery method for the vaccine—synthetic vaccinia and horsepox viruses—will prove more effective than others being tested around the world….

https://www.folio.ca/u-of-a-researchers-and-tonix-pharmaceuticals-race-to-develop-and-test-candidate-vaccines-for-covid-19/

Read More Impact Stories

Posted on
A comprehensive study by scientists at UdeM maps the evolutionary dynamics and risks of viral emergence of diseases that could [...]
Posted on
This article is available only in French. Infections respiratoires: mieux trier les patients pour soulager la pression sur les urgences [...]
Posted on
UBC’s Dr. James Lim is part of a research team helping to bring new hope to children battling hard-to-treat cancers. [...]